Diabetes does not affect ventricular repolarization and sudden cardiac death risk in patients with dilated

Bojan Vrtovec1, Misa Fister, Gregor Poglajen

  • 1Advanced Heart Failure Center, Department of Cardiology, Ljubljana University Medical Center, Ljubljana, Slovenia. gmrstabile@tin.it

Insights

Diabetes increases heart failure risk in dilated cardiomyopathy patients, but does not impact ventricular repolarization or sudden cardiac death. This study highlights diabetes as a predictor of mortality in DCM.

Area of Science:

  • Cardiology
  • Diabetology
  • Clinical Research

Background:

  • Dilated cardiomyopathy (DCM) is a significant cause of heart failure.
  • The impact of diabetes on cardiac outcomes in DCM patients requires further investigation.
  • Ventricular repolarization and sudden cardiac death are critical concerns in heart failure management.

Purpose of the Study:

  • To investigate the effects of diabetes on ventricular repolarization parameters.
  • To assess the association between diabetes and sudden cardiac death in patients with DCM.
  • To determine if diabetes influences overall mortality and heart failure-specific mortality in DCM.

Main Methods:

  • 132 patients with DCM (NYHA class II-III, LVEF <40%) were enrolled.
  • Patients were categorized into diabetic (n=45) and non-diabetic (n=87) groups.
  • High-resolution ECGs were used to determine QT variability (QTV) index, with 1-year follow-up for mortality.

Main Results:

  • Diabetes did not significantly alter QTV index compared to controls.
  • Overall mortality (20% vs 10%) and heart failure mortality (13% vs 2%) were higher in diabetic patients.
  • Diabetes predicted total and heart failure mortality, while high QTV predicted sudden cardiac death.

Conclusions:

  • Diabetes is associated with increased risk of heart failure mortality in DCM patients.
  • Ventricular repolarization parameters and sudden cardiac death risk are not significantly affected by diabetes in this cohort.
  • Diabetes is an independent predictor of adverse outcomes in DCM.
Abstract

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...